Intraoperative magnesium infusion as an adjuvant to bilateral single-injection thoracic paravertebral block for laparoscopic cholecystectomy

Phase 4

Completed

• Conditions: the postoperative period following laparoscopic cholesyctectomy; Anaesthesiology - Anaesthetics; Surgery - Surgical techniques

• Registration Number: ACTRN12612000001897
• Lead Sponsor: dr. waleed abdelmageed

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-01-03
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 59

Inclusion Criteria

ASA I-II patients scheduled for laparoscopic cholecystectomy.

Exclusion Criteria

history of cardiovascular disease or conduction disturbance, if they had impaired renal, hepatic or pulmonary functions, neuromuscular disease, coagulation disorder, obesity (body mass index >35kg.m2), a known allergy to magnesium sulphate, opioids or any other drug used in the study, or inability to use the patient-controlled analgesia (PCA) system).

Study & Design

• Study Type: Interventional
• Study Design: Not specified